{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T21:36:17Z","timestamp":1795210577046,"version":"4.10.3"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,2,6]],"date-time":"2023-02-06T00:00:00Z","timestamp":1675641600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,6]],"date-time":"2023-02-06T00:00:00Z","timestamp":1675641600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Various biomarkers targeting cell-free DNA (cfDNA) and circulating proteins have been tested for pan-cancer detection. Oncofetal chondroitin sulfate (ofCS), which distinctively modifies proteoglycans (PGs) of most cancer cells and binds specifically to the recombinant <jats:italic>Plasmodium falciparum<\/jats:italic> VAR2CSA proteins (rVAR2), is explored for its potential as a plasma biomarker in pan-cancer detection. To quantitate the plasma ofCS\/ofCSPGs, we optimized an ELISA using different capture\/detection pairs (rVAR2\/anti-CD44, -SDC1, and -CSPG4) in a case-control study with six cancer types. We show that the plasma levels of ofCS\/ofCSPGs are significantly higher in cancer patients (<jats:italic>P<\/jats:italic> values, 1.2 \u00d7 10<jats:sup>\u22122<\/jats:sup> to 4.4 \u00d7 10<jats:sup>\u221210<\/jats:sup>). Validation studies are performed with two independent cohorts covering 11 malignant tumors. The individuals in the top decile of ofCS-CD44 have more than 27-fold cancer risk (OR\u2009=\u200927.8, 95%CI\u2009=\u200918.8\u201341.4, <jats:italic>P<\/jats:italic>\u2009=\u20092.72 \u00d7 10<jats:sup>\u221262<\/jats:sup>) compared with the lowest 20%. Moreover, the elevated plasma ofCS-CD44 could be detected at the early stage of pan-cancer with strong dose-dependent odds risk prediction.<\/jats:p>","DOI":"10.1038\/s41467-023-36374-7","type":"journal-article","created":{"date-parts":[[2023,2,6]],"date-time":"2023-02-06T14:03:11Z","timestamp":1675692191000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Establishment and validation of a plasma oncofetal chondroitin sulfated proteoglycan for pan-cancer detection"],"prefix":"10.1038","volume":"14","author":[{"given":"Pei-Fen","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6207-381X","authenticated-orcid":false,"given":"Zi-Yi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Bin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Qiao","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kexin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0271-2098","authenticated-orcid":false,"given":"Tong-Min","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haixin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan-Hua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Da-Wei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-Mi","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7203-5240","authenticated-orcid":false,"given":"Ying","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Qiong","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lian-Jing","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi-Zhao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiang-Bo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si-Qi","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei-Qi","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6012-8389","authenticated-orcid":false,"given":"Jianbing","family":"Mu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0528-8715","authenticated-orcid":false,"given":"Wei-Hua","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,6]]},"reference":[{"key":"36374_CR1","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/s41571-020-00457-x","volume":"18","author":"M Ignatiadis","year":"2021","unstructured":"Ignatiadis, M., Sledge, G. W. & Jeffrey, S. S. Liquid biopsy enters the clinic - implementation issues and future challenges. Nat. Rev. Clin. Oncol. 18, 297\u2013312 (2021).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"36374_CR2","doi-asserted-by":"crossref","first-page":"184","DOI":"10.3322\/caac.21557","volume":"69","author":"RA Smith","year":"2019","unstructured":"Smith, R. A. et al. Cancer screening in the United States, 2019: a review of current American Cancer Society guidelines and current issues in cancer screening. CA Cancer J. Clin. 69, 184\u2013210 (2019).","journal-title":"CA Cancer J. Clin."},{"key":"36374_CR3","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1158\/1055-9965.EPI-20-1158","volume":"29","author":"RC Bast Jr","year":"2020","unstructured":"Bast, R. C. Jr. & Srivastava, S. The National Cancer Institute Early Detection Research Network: two decades of progress. Cancer Epidemiol. Biomark. Prev. 29, 2396\u20132400 (2020).","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"36374_CR4","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ccell.2020.05.021","volume":"38","author":"S Srivastava","year":"2020","unstructured":"Srivastava, S. & Hanash, S. Pan-cancer early detection: hype or hope? Cancer Cell 38, 23\u201324 (2020).","journal-title":"Cancer Cell"},{"key":"36374_CR5","unstructured":"Lennon, A. M. et al. Feasibility of blood testing combined with PET-CT to screen for cancer and guide intervention. Science 369, eabb9601 (2020)."},{"key":"36374_CR6","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.annonc.2020.02.011","volume":"31","author":"MC Liu","year":"2020","unstructured":"Liu, M. C., Oxnard, G. R., Klein, E. A., Swanton, C. & Seiden, M. V., Consortium C. Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA. Ann. Oncol. 31, 745\u2013759 (2020).","journal-title":"Ann. Oncol."},{"key":"36374_CR7","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1126\/science.aar3247","volume":"359","author":"JD Cohen","year":"2018","unstructured":"Cohen, J. D. et al. Detection and localization of surgically resectable cancers with a multi-analyte blood test. Science 359, 926\u2013930 (2018).","journal-title":"Science"},{"key":"36374_CR8","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.annonc.2021.05.806","volume":"32","author":"EA Klein","year":"2021","unstructured":"Klein, E. A. et al. Clinical validation of a targeted methylation-based multi-cancer early detection test using an independent validation set. Ann. Oncol. 32, 1167\u20131177 (2021).","journal-title":"Ann. Oncol."},{"key":"36374_CR9","volume":"12","author":"Y Zhang","year":"2021","unstructured":"Zhang, Y. et al. Pan-cancer circulating tumor DNA detection in over 10,000 Chinese patients. Nat. Commun. 12, 11 (2021).","journal-title":"Nat. Commun."},{"key":"36374_CR10","doi-asserted-by":"crossref","unstructured":"Wurdinger, T. In \u2018t Veld, S. G. J. G. & Best, M. G. Platelet RNA as Pan-tumor biomarker for cancer detection. Cancer Res. 80, 1371\u20131373 (2020).","DOI":"10.1158\/0008-5472.CAN-19-3684"},{"key":"36374_CR11","first-page":"297","volume":"26","author":"MKD Scott","year":"2021","unstructured":"Scott, M. K. D. et al. A multi-scale integrated analysis identifies KRT8 as a pan-cancer early biomarker. Pac Symp Biocomput. 26, 297\u2013308 (2021).","journal-title":"Pac Symp Biocomput."},{"key":"36374_CR12","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.cell.2020.07.009","volume":"182","author":"A Hoshino","year":"2020","unstructured":"Hoshino, A. et al. Extracellular vesicle and particle biomarkers define multiple human cancers. Cell 182, 1044\u20131061 e1018 (2020).","journal-title":"Cell"},{"key":"36374_CR13","volume":"2","author":"DA Ahlquist","year":"2018","unstructured":"Ahlquist, D. A. Universal cancer screening: revolutionary, rational, and realizable. NPJ Precis. Oncol. 2, 23 (2018).","journal-title":"NPJ Precis. Oncol."},{"key":"36374_CR14","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/nrc3982","volume":"15","author":"SS Pinho","year":"2015","unstructured":"Pinho, S. S. & Reis, C. A. Glycosylation in cancer: mechanisms and clinical implications. Nat. Rev. Cancer 15, 540\u2013555 (2015).","journal-title":"Nat. Rev. Cancer"},{"key":"36374_CR15","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.cell.2010.11.008","volume":"143","author":"GW Hart","year":"2010","unstructured":"Hart, G. W. & Copeland, R. J. Glycomics hits the big time. Cell 143, 672\u2013676 (2010).","journal-title":"Cell"},{"key":"36374_CR16","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ccell.2019.06.006","volume":"36","author":"S Mereiter","year":"2019","unstructured":"Mereiter, S., Balmana, M., Campos, D., Gomes, J. & Reis, C. A. Glycosylation in the Era of cancer-targeted therapy: where are we heading? Cancer Cell 36, 6\u201316 (2019).","journal-title":"Cancer Cell"},{"key":"36374_CR17","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nrurol.2012.258","volume":"10","author":"S Gilgunn","year":"2013","unstructured":"Gilgunn, S., Conroy, P. J., Saldova, R., Rudd, P. M. & O\u2019Kennedy, R. J. Aberrant PSA glycosylation-a sweet predictor of prostate cancer. Nat. Rev. Urol. 10, 99\u2013107 (2013).","journal-title":"Nat. Rev. Urol."},{"key":"36374_CR18","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.7150\/thno.15226","volume":"6","author":"E Llop","year":"2016","unstructured":"Llop, E. et al. Improvement of prostate cancer diagnosis by detecting PSA glycosylation-specific changes. Theranostics 6, 1190\u20131204 (2016).","journal-title":"Theranostics"},{"key":"36374_CR19","doi-asserted-by":"crossref","first-page":"845","DOI":"10.3390\/ijms18040845","volume":"18","author":"M Ferrer-Batalle","year":"2017","unstructured":"Ferrer-Batalle, M. et al. Comparative study of blood-based biomarkers, alpha2,3-sialic acid PSA and PHI, for high-risk prostate cancer detection. Int. J. Mol. Sci. 18, 845 (2017).","journal-title":"Int. J. Mol. Sci."},{"key":"36374_CR20","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1126\/science.aaw3145","volume":"364","author":"DD Engle","year":"2019","unstructured":"Engle, D. D. et al. The glycan CA19-9 promotes pancreatitis and pancreatic cancer in mice. Science 364, 1156\u20131162 (2019).","journal-title":"Science"},{"key":"36374_CR21","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1158\/1078-0432.CCR-18-3310","volume":"25","author":"B Staal","year":"2019","unstructured":"Staal, B. et al. The sTRA plasma biomarker: blinded validation of improved accuracy over CA19-9 in pancreatic cancer diagnosis. Clin. Cancer Res. 25, 2745\u20132754 (2019).","journal-title":"Clin. Cancer Res."},{"key":"36374_CR22","doi-asserted-by":"crossref","first-page":"eaah5583","DOI":"10.1126\/scitranslmed.aah5583","volume":"9","author":"J Kim","year":"2017","unstructured":"Kim, J. et al. Detection of early pancreatic ductal adenocarcinoma with thrombospondin-2 and CA19-9 blood markers. Sci. Transl. Med. 9, eaah5583 (2017).","journal-title":"Sci. Transl. Med."},{"key":"36374_CR23","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.ccell.2015.09.003","volume":"28","author":"A Salanti","year":"2015","unstructured":"Salanti, A. et al. Targeting human cancer by a glycosaminoglycan binding malaria protein. Cancer Cell 28, 500\u2013514 (2015).","journal-title":"Cancer Cell"},{"key":"36374_CR24","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1111\/j.1742-4658.2012.08529.x","volume":"279","author":"N Afratis","year":"2012","unstructured":"Afratis, N. et al. Glycosaminoglycans: key players in cancer cell biology and treatment. FEBS J. 279, 1177\u20131197 (2012).","journal-title":"FEBS J."},{"key":"36374_CR25","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1158\/1541-7786.MCR-16-0103","volume":"14","author":"TM Clausen","year":"2016","unstructured":"Clausen, T. M. et al. Oncofetal chondroitin sulfate glycosaminoglycans are key players in integrin signaling and tumor cell motility. Mol. Cancer Res. 14, 1288\u20131299 (2016).","journal-title":"Mol. Cancer Res."},{"key":"36374_CR26","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1093\/glycob\/cwaa039","volume":"30","author":"AG Toledo","year":"2020","unstructured":"Toledo, A. G. et al. An affinity chromatography and glycoproteomics workflow to profile the chondroitin sulfate proteoglycans that interact with malarial VAR2CSA in the placenta and in cancer. Glycobiology 30, 989\u20131002 (2020).","journal-title":"Glycobiology"},{"key":"36374_CR27","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/s41420-020-00304-z","volume":"6","author":"TM Clausen","year":"2020","unstructured":"Clausen, T. M. et al. A simple method for detecting oncofetal chondroitin sulfate glycosaminoglycans in bladder cancer urine. Cell Death Disco. 6, 65 (2020).","journal-title":"Cell Death Disco."},{"key":"36374_CR28","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/s41564-020-00858-9","volume":"6","author":"R Ma","year":"2021","unstructured":"Ma, R. et al. Structural basis for placental malaria mediated by Plasmodium falciparum VAR2CSA. Nat. Microbiol. 6, 380\u2013391 (2021).","journal-title":"Nat. Microbiol."},{"key":"36374_CR29","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1126\/science.272.5267.1502","volume":"272","author":"M Fried","year":"1996","unstructured":"Fried, M. & Duffy, P. E. Adherence of Plasmodium falciparum to chondroitin sulfate A in the human placenta. Science 272, 1502\u20131504 (1996).","journal-title":"Science"},{"key":"36374_CR30","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1146\/annurev-micro-090816-093841","volume":"71","author":"KW Deitsch","year":"2017","unstructured":"Deitsch, K. W. & Dzikowski, R. Variant gene expression and antigenic variation by malaria parasites. Annu. Rev. Microbiol. 71, 625\u2013641 (2017).","journal-title":"Annu. Rev. Microbiol."},{"key":"36374_CR31","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-05793-2","volume":"9","author":"MO Agerbaek","year":"2018","unstructured":"Agerbaek, M. O. et al. The VAR2CSA malaria protein efficiently retrieves circulating tumor cells in an EpCAM-independent manner. Nat. Commun. 9, 3279 (2018).","journal-title":"Nat. Commun."},{"key":"36374_CR32","doi-asserted-by":"crossref","first-page":"998","DOI":"10.3390\/cells8090998","volume":"8","author":"SR Bang-Christensen","year":"2019","unstructured":"Bang-Christensen, S. R. et al. Capture and detection of circulating glioma cells using the recombinant VAR2CSA malaria protein. Cells 8, 998 (2019).","journal-title":"Cells"},{"key":"36374_CR33","doi-asserted-by":"crossref","first-page":"e20270","DOI":"10.1371\/journal.pone.0020270","volume":"6","author":"A Srivastava","year":"2011","unstructured":"Srivastava, A. et al. Var2CSA minimal CSA binding region is located within the N-terminal region. PLoS ONE 6, e20270 (2011).","journal-title":"PLoS ONE"},{"key":"36374_CR34","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/j.ijpara.2009.02.022","volume":"39","author":"M Resende","year":"2009","unstructured":"Resende, M. et al. Chondroitin sulphate A (CSA)-binding of single recombinant Duffy-binding-like domains is not restricted to Plasmodium falciparum erythrocyte membrane protein 1 expressed by CSA-binding parasites. Int. J. Parasitol. 39, 1195\u20131204 (2009).","journal-title":"Int. J. Parasitol."},{"key":"36374_CR35","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.jmb.2010.01.040","volume":"397","author":"P Khunrae","year":"2010","unstructured":"Khunrae, P. et al. Full-length recombinant Plasmodium falciparum VAR2CSA binds specifically to CSPG and induces potent parasite adhesion-blocking antibodies. J. Mol. Biol. 397, 826\u2013834 (2010).","journal-title":"J. Mol. Biol."},{"key":"36374_CR36","doi-asserted-by":"crossref","first-page":"15908","DOI":"10.1074\/jbc.M110.191510","volume":"286","author":"M Dahlback","year":"2011","unstructured":"Dahlback, M. et al. The chondroitin sulfate A-binding site of the VAR2CSA protein involves multiple N-terminal domains. J. Biol. Chem. 286, 15908\u201315917 (2011).","journal-title":"J. Biol. Chem."},{"key":"36374_CR37","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1038\/s42003-021-02787-7","volume":"4","author":"JP Renn","year":"2021","unstructured":"Renn, J. P. et al. Allelic variants of full-length VAR2CSA, the placental malaria vaccine candidate, differ in antigenicity and receptor binding affinity. Commun. Biol. 4, 1309 (2021).","journal-title":"Commun. Biol."},{"key":"36374_CR38","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0016-5085(03)00689-9","volume":"125","author":"M Capurro","year":"2003","unstructured":"Capurro, M. et al. Glypican-3: a novel serum and histochemical marker for hepatocellular carcinoma. Gastroenterology 125, 89\u201397 (2003).","journal-title":"Gastroenterology"},{"key":"36374_CR39","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1002\/ijc.25778","volume":"128","author":"JW Pedersen","year":"2011","unstructured":"Pedersen, J. W. et al. Seromic profiling of colorectal cancer patients with novel glycopeptide microarray. Int. J. Cancer 128, 1860\u20131871 (2011).","journal-title":"Int. J. Cancer"},{"key":"36374_CR40","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.cell.2021.02.020","volume":"184","author":"WC Hahn","year":"2021","unstructured":"Hahn, W. C. et al. An expanded universe of cancer targets. Cell 184, 1142\u20131155 (2021).","journal-title":"Cell"},{"key":"36374_CR41","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.cell.2013.03.002","volume":"153","author":"LA Garraway","year":"2013","unstructured":"Garraway, L. A. & Lander, E. S. Lessons from the cancer genome. Cell 153, 17\u201337 (2013).","journal-title":"Cell"},{"key":"36374_CR42","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.cell.2016.12.039","volume":"168","author":"MG Vander Heiden","year":"2017","unstructured":"Vander Heiden, M. G. & DeBerardinis, R. J. Understanding the Intersections between metabolism and cancer biology. Cell 168, 657\u2013669 (2017).","journal-title":"Cell"},{"key":"36374_CR43","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1136\/jcp.2009.071035","volume":"63","author":"CA Reis","year":"2010","unstructured":"Reis, C. A., Osorio, H., Silva, L., Gomes, C. & David, L. Alterations in glycosylation as biomarkers for cancer detection. J. Clin. Pathol. 63, 322\u2013329 (2010).","journal-title":"J. Clin. Pathol."},{"key":"36374_CR44","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1038\/s41416-020-01223-7","volume":"124","author":"MC Liu","year":"2021","unstructured":"Liu, M. C. Transforming the landscape of early cancer detection using blood tests-Commentary on current methodologies and future prospects. Br. J. Cancer 124, 1475\u20131477 (2021).","journal-title":"Br. J. Cancer"},{"key":"36374_CR45","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ccell.2022.01.012","volume":"40","author":"A Hackshaw","year":"2022","unstructured":"Hackshaw, A., Clarke, C. A. & Hartman, A. R. New genomic technologies for multi-cancer early detection: rethinking the scope of cancer screening. Cancer Cell 40, 109\u2013113 (2022).","journal-title":"Cancer Cell"},{"key":"36374_CR46","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/jnci\/djab168","volume":"114","author":"R Etzioni","year":"2022","unstructured":"Etzioni, R., Gulati, R. & Weiss, N. S. Multicancer early detection: learning from the past to meet the future. J. Natl Cancer Inst. 114, 349\u2013352 (2022).","journal-title":"J. Natl Cancer Inst."},{"key":"36374_CR47","doi-asserted-by":"crossref","first-page":"e1005234","DOI":"10.1371\/journal.pgen.1005234","volume":"11","author":"UE Ukaegbu","year":"2015","unstructured":"Ukaegbu, U. E. et al. A unique virulence gene occupies a principal position in immune evasion by the malaria parasite Plasmodium falciparum. PLoS Genet. 11, e1005234 (2015).","journal-title":"PLoS Genet."},{"key":"36374_CR48","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1111\/mmi.12379","volume":"90","author":"C Bancells","year":"2013","unstructured":"Bancells, C. & Deitsch, K. W. A molecular switch in the efficiency of translation reinitiation controls expression of var2csa, a gene implicated in pregnancy-associated malaria. Mol. Microbiol. 90, 472\u2013488 (2013).","journal-title":"Mol. Microbiol."},{"key":"36374_CR49","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.3390\/ijms21072401","volume":"21","author":"NT Sand","year":"2020","unstructured":"Sand, N. T. et al. Optimization of rVAR2-based isolation of cancer cells in blood for building a robust assay for clinical detection of circulating tumor cells. Int. J. Mol. Sci. 21, 2401 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"36374_CR50","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/s42003-019-0704-z","volume":"2","author":"JYA Doritchamou","year":"2019","unstructured":"Doritchamou, J. Y. A. et al. Placental malaria vaccine candidate antigen VAR2CSA displays atypical domain architecture in some Plasmodium falciparum strains. Commun. Biol. 2, 457 (2019).","journal-title":"Commun. Biol."},{"key":"36374_CR51","doi-asserted-by":"crossref","first-page":"e201910070","DOI":"10.1083\/jcb.201910070","volume":"219","author":"A Buffone","year":"2020","unstructured":"Buffone, A. & Weaver, V. M. Don\u2019t sugarcoat it: how glycocalyx composition influences cancer progression. J. Cell Biol. 219, e201910070 (2020).","journal-title":"J. Cell Biol."},{"key":"36374_CR52","doi-asserted-by":"crossref","first-page":"1235681","DOI":"10.1126\/science.1235681","volume":"343","author":"M Dalziel","year":"2014","unstructured":"Dalziel, M., Crispin, M., Scanlan, C. N., Zitzmann, N. & Dwek, R. A. Emerging principles for the therapeutic exploitation of glycosylation. Science 343, 1235681 (2014).","journal-title":"Science"},{"key":"36374_CR53","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1093\/glycob\/cwy023","volume":"28","author":"OMT Pearce","year":"2018","unstructured":"Pearce, O. M. T. Cancer glycan epitopes: biosynthesis, structure and function. Glycobiology 28, 670\u2013696 (2018).","journal-title":"Glycobiology"},{"key":"36374_CR54","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/bs.acr.2014.11.005","volume":"126","author":"A Mehta","year":"2015","unstructured":"Mehta, A., Herrera, H. & Block, T. Glycosylation and liver cancer. Adv. Cancer Res. 126, 257\u2013279 (2015).","journal-title":"Adv. Cancer Res."},{"key":"36374_CR55","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/s41392-020-0134-x","volume":"5","author":"J Fares","year":"2020","unstructured":"Fares, J., Fares, M. Y., Khachfe, H. H., Salhab, H. A. & Fares, Y. Molecular principles of metastasis: a hallmark of cancer revisited. Signal Transduct. Target Ther. 5, 28 (2020).","journal-title":"Signal Transduct. Target Ther."},{"key":"36374_CR56","doi-asserted-by":"crossref","first-page":"749","DOI":"10.3389\/fcell.2020.00749","volume":"8","author":"TD Ahrens","year":"2020","unstructured":"Ahrens, T. D. et al. The role of proteoglycans in cancer metastasis and circulating tumor cell analysis. Front. Cell Dev. Biol. 8, 749 (2020).","journal-title":"Front. Cell Dev. Biol."},{"key":"36374_CR57","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3389\/fcell.2017.00018","volume":"5","author":"LT Senbanjo","year":"2017","unstructured":"Senbanjo, L. T. & Chellaiah, M. A. CD44: a multifunctional cell surface adhesion receptor is a regulator of progression and metastasis of cancer cells. Front. Cell Dev. Biol. 5, 18 (2017).","journal-title":"Front. Cell Dev. Biol."},{"key":"36374_CR58","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.3390\/ijms22031463","volume":"22","author":"R Szatanek","year":"2021","unstructured":"Szatanek, R. & Baj-Krzyworzeka, M. CD44 and tumor-derived extracellular vesicles (TEVs). possible gateway to cancer metastasis. Int. J. Mol. Sci. 22, 1463 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"36374_CR59","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.3389\/fimmu.2017.01911","volume":"8","author":"KM Ilieva","year":"2017","unstructured":"Ilieva, K. M. et al. Chondroitin sulfate proteoglycan 4 and its potential as an antibody immunotherapy target across different tumor types. Front. Immunol. 8, 1911 (2017).","journal-title":"Front. Immunol."},{"key":"36374_CR60","doi-asserted-by":"crossref","first-page":"5942","DOI":"10.3390\/ijms20235942","volume":"20","author":"DC Harrer","year":"2019","unstructured":"Harrer, D. C., Dorrie, J. & Schaft, N. CSPG4 as target for CAR-T-cell therapy of various tumor entities-merits and challenges. Int. J. Mol. Sci. 20, 5942 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"36374_CR61","doi-asserted-by":"crossref","first-page":"28693","DOI":"10.18632\/oncotarget.4981","volume":"6","author":"MR Akl","year":"2015","unstructured":"Akl, M. R. et al. Molecular and clinical profiles of syndecan-1 in solid and hematological cancer for prognosis and precision medicine. Oncotarget 6, 28693\u201328715 (2015).","journal-title":"Oncotarget"},{"key":"36374_CR62","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1136\/gutjnl-2016-312794","volume":"67","author":"JH Rho","year":"2018","unstructured":"Rho, J. H. et al. Protein and glycomic plasma markers for early detection of adenoma and colon cancer. Gut 67, 473\u2013484 (2018).","journal-title":"Gut"},{"key":"36374_CR63","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-019-5556-x","volume":"19","author":"A Torres","year":"2019","unstructured":"Torres, A. et al. CD44, TGM2 and EpCAM as novel plasma markers in endometrial cancer diagnosis. BMC Cancer 19, 401 (2019).","journal-title":"BMC Cancer"},{"key":"36374_CR64","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/s43018-020-0043-5","volume":"1","author":"DW Cescon","year":"2020","unstructured":"Cescon, D. W., Bratman, S. V., Chan, S. M. & Siu, L. L. Circulating tumor DNA and liquid biopsy in oncology. Nat. Cancer 1, 276\u2013290 (2020).","journal-title":"Nat. Cancer"},{"key":"36374_CR65","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.annonc.2021.01.074","volume":"32","author":"W Yu","year":"2021","unstructured":"Yu, W. et al. Exosome-based liquid biopsies in cancer: opportunities and challenges. Ann. Oncol. 32, 466\u2013477 (2021).","journal-title":"Ann. Oncol."},{"key":"36374_CR66","doi-asserted-by":"crossref","first-page":"4357","DOI":"10.1128\/IAI.01617-05","volume":"74","author":"L Barfod","year":"2006","unstructured":"Barfod, L. et al. Baculovirus-expressed constructs induce immunoglobulin G that recognizes VAR2CSA on Plasmodium falciparum-infected erythrocytes. Infect. Immun. 74, 4357\u20134360 (2006).","journal-title":"Infect. Immun."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-36374-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-36374-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-36374-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,6]],"date-time":"2023-02-06T14:06:12Z","timestamp":1675692372000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-36374-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,6]]},"references-count":66,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["36374"],"URL":"https:\/\/doi.org\/10.1038\/s41467-023-36374-7","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,6]]},"assertion":[{"value":"26 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"645"}}